How can we help enable your research?

Adarza has additional R&D programs around several next-generation products, including multiplexed kinase assays for high-throughput small molecule screening, and is actively seeking commercial partners to further validate products that address unmet needs in life science research and clinical diagnostics.

Our partnerships are leading to accelerated development of new biosensing assays across all phases of academic and clinical research, ranging from massively multiplexed discovery screens to smaller, focused panels suitable for deployment in the clinic. All using the same technology and affordable instrumentation.

If you think your research could benefit from Adarza’s disruptive platform technology, we welcome your inquiry on how we might work together to improve and accelerate your research.

For additional information, please contact:

Bryan J. Witherbee
President and CEO
Adarza BioSystems, Inc.